Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
1.
Microb Genom ; 8(1)2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-35040428

RESUMEN

The development of spots or lesions symptomatic of common scab on root and tuber crops is caused by few pathogenic Streptomyces with Streptomyces scabiei 87-22 as the model species. Thaxtomin phytotoxins are the primary virulence determinants, mainly acting by impairing cellulose synthesis, and their production in S. scabiei is in turn boosted by cello-oligosaccharides released from host plants. In this work we aimed to determine which molecules and which biosynthetic gene clusters (BGCs) of the specialized metabolism of S. scabiei 87-22 show a production and/or a transcriptional response to cello-oligosaccharides. Comparative metabolomic analyses revealed that molecules of the virulome of S. scabiei induced by cellobiose and cellotriose include (i) thaxtomin and concanamycin phytotoxins, (ii) desferrioxamines, scabichelin and turgichelin siderophores in order to acquire iron essential for housekeeping functions, (iii) ectoine for protection against osmotic shock once inside the host, and (iv) bottromycin and concanamycin antimicrobials possibly to prevent other microorganisms from colonizing the same niche. Importantly, both cello-oligosaccharides reduced the production of the spore germination inhibitors germicidins thereby giving the 'green light' to escape dormancy and trigger the onset of the pathogenic lifestyle. For most metabolites - either with induced or reduced production - cellotriose was revealed to be a slightly stronger elicitor compared to cellobiose, supporting an earlier hypothesis which suggested the trisaccharide was the real trigger for virulence released from the plant cell wall through the action of thaxtomins. Interestingly, except for thaxtomins, none of these BGCs' expression seems to be under direct control of the cellulose utilization repressor CebR suggesting the existence of a yet unknown mechanism for switching on the virulome. Finally, a transcriptomic analysis revealed nine additional cryptic BGCs that have their expression awakened by cello-oligosaccharides, suggesting that other and yet to be discovered metabolites could be part of the virulome of S. scabiei.


Asunto(s)
Vías Biosintéticas/efectos de los fármacos , Celobiosa/farmacología , Celulosa/farmacología , Tubérculos de la Planta/microbiología , Streptomyces/crecimiento & desarrollo , Triosas/farmacología , Factores de Virulencia/metabolismo , Perfilación de la Expresión Génica , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Macrólidos/metabolismo , Metabolómica , Familia de Multigenes/efectos de los fármacos , Piperazinas/metabolismo , Tubérculos de la Planta/crecimiento & desarrollo , RNA-Seq , Streptomyces/efectos de los fármacos , Streptomyces/metabolismo , Streptomyces/patogenicidad
2.
Biochem J ; 475(16): 2637-2652, 2018 08 30.
Artículo en Inglés | MEDLINE | ID: mdl-30049894

RESUMEN

Dihydroxyacetone (DHA) is the smallest ketotriose, and it is utilized by many organisms as an energy source. However, at higher concentrations, DHA becomes toxic towards several organisms including the budding yeast Saccharomyces cerevisiae In the present study, we show that DHA toxicity is due to its spontaneous conversion to methylglyoxal (MG) within yeast cells. A mutant defective in MG-metabolizing enzymes (glo1Δgre2Δgre3Δ) exhibited higher susceptibility to DHA. Intracellular MG levels increased following the treatment of glo1Δgre2Δgre3Δ cells with DHA. We previously reported that MG depolarized the actin cytoskeleton and changed vacuolar morphology. We herein demonstrated the depolarization of actin and morphological changes in vacuoles following a treatment with DHA. Furthermore, we found that both MG and DHA caused the morphological change in nucleus, and inhibited the nuclear division. Our results suggest that the conversion of DHA to MG is a dominant contributor to its cytotoxicity.


Asunto(s)
Actinas/metabolismo , División del Núcleo Celular/efectos de los fármacos , Citotoxinas/farmacología , Glioxal , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Triosas/farmacología , Actinas/genética , Glioxal/análogos & derivados , Glioxal/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética
3.
Proc Natl Acad Sci U S A ; 109(16): 6012-7, 2012 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-22474347

RESUMEN

Neurospora crassa colonizes burnt grasslands in the wild and metabolizes both cellulose and hemicellulose from plant cell walls. When switched from a favored carbon source such as sucrose to cellulose, N. crassa dramatically upregulates expression and secretion of a wide variety of genes encoding lignocellulolytic enzymes. However, the means by which N. crassa and other filamentous fungi sense the presence of cellulose in the environment remains unclear. Here, we show that an N. crassa mutant carrying deletions of two genes encoding extracellular ß-glucosidase enzymes and one intracellular ß-glucosidase lacks ß-glucosidase activity, but efficiently induces cellulase gene expression in the presence of cellobiose, cellotriose, or cellotetraose as a sole carbon source. These data indicate that cellobiose, or a modified version of cellobiose, functions as an inducer of lignocellulolytic gene expression in N. crassa. Furthermore, the inclusion of a deletion of the catabolite repressor gene, cre-1, in the triple ß-glucosidase mutant resulted in a strain that produces higher concentrations of secreted active cellulases on cellobiose. Thus, the ability to induce cellulase gene expression using a common and soluble carbon source simplifies enzyme production and characterization, which could be applied to other cellulolytic filamentous fungi.


Asunto(s)
Celulasa/genética , Celulasas/genética , Celulosa/análogos & derivados , Dextrinas/farmacología , Proteínas Fúngicas/genética , Neurospora crassa/genética , Celobiosa/metabolismo , Celobiosa/farmacología , Celulasa/metabolismo , Celulasas/clasificación , Celulasas/metabolismo , Celulosa/metabolismo , Celulosa/farmacología , Análisis por Conglomerados , Dextrinas/metabolismo , Proteínas Fúngicas/metabolismo , Eliminación de Gen , Perfilación de la Expresión Génica , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Lignina/metabolismo , Lignina/farmacología , Espectrometría de Masas , Mutación , Neurospora crassa/metabolismo , Filogenia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tetrosas/metabolismo , Tetrosas/farmacología , Triosas/metabolismo , Triosas/farmacología
4.
Chem Res Toxicol ; 21(9): 1841-50, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18729331

RESUMEN

Aminoacetone (AA), triose phosphates, and acetone are putative endogenous sources of potentially cytotoxic and genotoxic methylglyoxal (MG), which has been reported to be augmented in the plasma of diabetic patients. In these patients, accumulation of MG derived from aminoacetone, a threonine and glycine catabolite, is inferred from the observed concomitant endothelial overexpression of circulating semicarbazide-sensitive amine oxidases. These copper-dependent enzymes catalyze the oxidation of primary amines, such as AA and methylamine, by molecular oxygen, to the corresponding aldehydes, NH4(+) ion and H2O2. We recently reported that AA aerobic oxidation to MG also takes place immediately upon addition of catalytic amounts of copper and iron ions. Taking into account that (i) MG and H2O2 are reportedly cytotoxic to insulin-producing cell lineages such as RINm5f and that (ii) the metal-catalyzed oxidation of AA is propagated by O2(*-) radical anion, we decided to investigate the possible pro-oxidant action of AA on these cells taken here as a reliable model system for pancreatic beta-cells. Indeed, we show that AA (0.10-5.0 mM) administration to RINm5f cultures induces cell death. Ferrous (50-300 microM) and Fe(3+) ion (100 microM) addition to the cell cultures had no effect, whereas Cu(2+) (5.0-100 microM) significantly increased cell death. Supplementation of the AA- and Cu(2+)-containing culture medium with antioxidants, such as catalase (5.0 microM), superoxide dismutase (SOD, 50 U/mL), and N-acetylcysteine (NAC, 5.0 mM) led to partial protection. mRNA expression of MnSOD, CuZnSOD, glutathione peroxidase, and glutathione reductase, but not of catalase, is higher in cells treated with AA (0.50-1.0 mM) plus Cu(2+) ions (10-50 microM) relative to control cultures. This may imply higher activity of antioxidant enzymes in RINm5f AA-treated cells. In addition, we have found that AA (0.50-1.0 mM) plus Cu(2+) (100 microM) (i) increase RINm5f cytosolic calcium; (ii) promote DNA fragmentation; and (iii) increase the pro-apoptotic (Bax)/antiapoptotic (Bcl-2) ratio at the level of mRNA expression. In conclusion, although both normal and pathological concentrations of AA are probably much lower than those used here, it is tempting to propose that excess AA in diabetic patients may drive oxidative damage and eventually the death of pancreatic beta-cells.


Asunto(s)
Acetona/análogos & derivados , Insulina/metabolismo , Estrés Oxidativo/efectos de los fármacos , Acetona/química , Acetona/farmacología , Acetilcisteína/farmacología , Animales , Antioxidantes/farmacología , Catalasa/farmacología , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cobre/farmacología , Relación Dosis-Respuesta a Droga , Secreción de Insulina , Ratones , Estructura Molecular , Células 3T3 NIH , ARN Mensajero/metabolismo , Superóxido Dismutasa/farmacología , Triosas/farmacología
5.
Biochem Pharmacol ; 57(6): 583-8, 1999 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-10037441

RESUMEN

Trioses, such as D-glyceraldehyde, have been used extensively for the study of stimulus-secretion coupling mechanisms in pancreatic beta-cells. It is generally assumed that trioses enter the glycolytic pathway at the triose phosphate level, and stimulate insulin release in a manner analogous to glucose. This review focuses on a number of triose effects that are not entirely consistent with this model. These effects are likely to result, at least in part, from the actions of alpha-ketoaldehydes. One such compound, methylglyoxal, appears to be a major contaminant of triose preparations, and exerts effects on the beta-cell identical to some of those evoked by glyceraldehyde. A related substance, hydroxypyruvaldehyde, is a product of triose autoxidation, which could exert similar effects. Study of the actions of trioses and alpha-ketoaldehydes could assist our understanding of cellular physiology, in general, and beta-cell function, in particular. These substances are also likely to be of pathophysiological importance, especially in the context of sugar toxicity and autoxidative cell damage.


Asunto(s)
Insulina/metabolismo , Islotes Pancreáticos/efectos de los fármacos , Triosas/farmacología , Animales , Células Cultivadas , Gliceraldehído/farmacología , Glucólisis , Secreción de Insulina , Islotes Pancreáticos/metabolismo , Lactoilglutatión Liasa/metabolismo , Oxidación-Reducción , Piruvaldehído/metabolismo , Piruvaldehído/farmacología
6.
Ukr Biokhim Zh (1978) ; 62(1): 108-12, 1990.
Artículo en Ruso | MEDLINE | ID: mdl-2336719

RESUMEN

Citrate and dihydroxyacetone inhibited [14C] incorporation from radioactive methanol to CO2 by washed cells of methylotrophic yeast Hansenula polymorpha grown in the media containing mixture of methanol with citrate or dihydroxyacetone, respectively. These results are discussed in connection with the earlier hypothesis on participation of the tricarboxylic acid cycle in the energy supply of the methylotrophic growth.


Asunto(s)
Citratos/farmacología , Dihidroxiacetona/farmacología , Metanol/metabolismo , Pichia/metabolismo , Saccharomycetales/metabolismo , Triosas/farmacología , Ácido Cítrico , Oxidación-Reducción , Pichia/efectos de los fármacos
7.
J Appl Physiol (1985) ; 68(1): 119-24, 1990 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2312449

RESUMEN

The effects of dietary supplementation of dihydroxyacetone and pyruvate (DHAP) on endurance capacity and metabolic responses during arm exercise were determined in 10 untrained males (20-26 yr). Subjects performed arm ergometer exercise (60% peak O2 consumption) to exhaustion after consumption of standard diets (55% carbohydrate, 15% protein, 30% fat; 35 kcal/kg) containing either 100 g of Polycose (placebo, P) or DHAP (3:1, treatment) substituted for a portion of carbohydrate. The two diets were administered in a random order, and each was consumed for a 7-day period. Biopsy of the triceps muscle was obtained immediately before and after exercise. Blood samples were drawn through radial artery and axillary vein catheters at rest, after 60 min of exercise, and at exercise termination. Arm endurance was 133 +/- 20 min after P and 160 +/- 22 min after DHAP (P less than 0.01). Triceps glycogen at rest was 88 +/- 8 (P) and 130 +/- 19 mmol/kg (DHAP) (P less than 0.05). Whole arm arteriovenous glucose difference (mmol/l) was greater (P less than 0.05) for DHAP than P at rest (0.60 +/- 0.12 vs. 0.05 +/- 0.09) and after 60 min of exercise (1.00 +/- 0.12 vs. 0.36 +/- 0.11), but it did not differ at exhaustion. Neither respiratory exchange ratio nor respiratory quotient differed between trials at rest, after 60 min of exercise, or at exhaustion. Plasma free fatty acid, glycerol, beta-hydroxybutyrate, catecholamines, and insulin were similar during rest and exercise for both diets. Feeding DHAP for 7 days increased arm muscle glucose extraction before and during exercise, thereby enhancing submaximal arm endurance capacity.


Asunto(s)
Brazo/fisiología , Carbohidratos de la Dieta/farmacología , Dihidroxiacetona/farmacología , Ejercicio Físico/fisiología , Resistencia Física/efectos de los fármacos , Piruvatos/farmacología , Triosas/farmacología , Adulto , Dieta , Dihidroxiacetona/administración & dosificación , Método Doble Ciego , Glucógeno/análisis , Humanos , Masculino , Músculos/análisis , Piruvatos/administración & dosificación
8.
J Anim Sci ; 67(5): 1272-8, 1989 May.
Artículo en Inglés | MEDLINE | ID: mdl-2737983

RESUMEN

Swine weighing 80 to 85 kg were fed a basal corn-soybean meal diet plus a mixture of dihydroxyacetone and pyruvate (3:1) (triose) or Polycose (control), a glucose polymer, as 3.85% of calories (4% of the diet). Twenty-four pigs were pair-fed the triose mixture or control diet for 28 d in litter-mate pairs of the same sex. Weight gain and feed consumption were recorded and carcasses were evaluated for fat and muscle accretion. The right rear leg and rear one-third of the right loin were skinned, deboned, ground and analyzed for protein, fat, moisture and ash content. Average backfat depth and backfat depth at the first, last and 10th rib were reduced by 12, 15, 14 and 12% (P less than .01), respectively, in triose-fed pigs. Loin eye area and untrimmed lean cuts were not altered by diet, but percentage trimmed lean cuts was higher (P less than .02) in triose-fed pigs (57.6 vs 55.3%). Leg and loin tissue samples from pigs fed the triose mixture had a lower (P less than .01) percentage of fat and a corresponding increased (P less than .01) percentage of protein. Organ weights and the blood biochemical profile were not altered by triose feeding. Liver function tests were not altered in animals consuming the trioses, except for an 18% decrease (P less than .05) in serum glutamic pyruvic transaminase. Ingestion of dihydroxyacetone and pyruvate will reduce body fat in limit-fed swine without reducing muscle protein deposition.


Asunto(s)
Tejido Adiposo/efectos de los fármacos , Composición Corporal/efectos de los fármacos , Dihidroxiacetona/farmacología , Piruvatos/farmacología , Porcinos/crecimiento & desarrollo , Triosas/farmacología , Alimentación Animal , Animales , Colesterol/sangre , Ingestión de Alimentos , Femenino , Recuento de Leucocitos/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Porcinos/metabolismo , Aumento de Peso/efectos de los fármacos
9.
Arch Biochem Biophys ; 271(1): 130-8, 1989 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-2712570

RESUMEN

Glycerol is a dietary component which is metabolized primarily by the liver and kidney where it is used mainly for glucose synthesis. The metabolism of glycerol is very similar to that of dihydroxyacetone which can be considered its more oxidized counterpart. The effects of these substrates on hepatic lipogenesis and gluconeogenesis were examined. In isolated hepatocytes, 10 mM dihydroxyacetone caused a large increase in glucose output and stimulated lipogenesis without affecting the lactate/pyruvate ratio or the total ATP content of the cells. (As compared to dihydroxyacetone, 10 mM glycerol was less effective as a gluconeogenic substrate, increased the lactate/pyruvate ratio, caused a slight decrease in the total ATP content, and inhibited lipogenesis by at least 40% depending on the type of diet fed to the rats.) The fall in ATP levels was very small and did not correlate with the changes in fatty acid synthesis. The immediate cause of the inhibition of lipogenesis, brought about by glycerol in hepatocytes from sucrose fed rats, seemed to be a large decrease in pyruvate levels. This did not result from impairment of glycolysis but from a rise in the cytosolic NADH/NAD ratio.


Asunto(s)
Dihidroxiacetona/farmacología , Glicerol/farmacología , Lípidos/biosíntesis , Hígado/metabolismo , Triosas/farmacología , Ácido 3-Hidroxibutírico , Acetoacetatos/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Células Cultivadas , Carbohidratos de la Dieta/administración & dosificación , Femenino , Glucosa/metabolismo , Hidroxibutiratos/metabolismo , Cuerpos Cetónicos/metabolismo , Lactatos/metabolismo , Hígado/efectos de los fármacos , Piruvatos/metabolismo , Ratas , Ratas Endogámicas , Estadística como Asunto , Tetrametilfenilendiamina/farmacología
10.
Biochem Med Metab Biol ; 37(2): 228-34, 1987 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2954569

RESUMEN

Metabolic regulation of gluconeogenesis and glycogenolysis by two phosphorylated derivatives of glycerol, G3P, and DHAP, and by F2,6BP, was assessed in vitro in liver homogenates obtained from Chinese hamsters (C. griseus) of two types: diabetic animals from sublines with consistent glycosuria and hyperglycemia, and normoglycemic controls. Only FBPase was sensitive to inhibition by the phosphorylated metabolites. G3P was weakly inhibitory of FBPase. Addition of 7 X 10(-3) M DHAP halved FBPase activity in the diabetic hamsters and 4 X 10(-3) M DHAP produced the same effect in the controls. The other gluconeogenic enzymes and phosphorylase a were only negligibly inhibited. In contrast, F2,6BP inhibited FBPase at concentrations in the micromolar range. Liver homogenates from diabetic hamsters appeared significantly more sensitive to F2,6BP inhibition of FBPase than those from controls at concentrations 0.6 X 10(-6) M and higher. These data indicate that in well-fed hamsters phosphorylated glycerol derivatives are unlikely to regulate hepatic gluconeogenesis at physiologic concentrations. However, the effects of F2,6BP on gluconeogenesis and glycolysis may be linked to those mediated by insulin. Thus, the deficiency of insulin, elevated end-organ insulin resistance, the alteration in the glucagon-insulin interaction, or a combination of these possible causes can be involved in an abnormal regulation of glycolysis and gluconeogenesis at the FBPase step, associated with changes in F2,6BP concentration.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Dihidroxiacetona Fosfato/farmacología , Gluconeogénesis/efectos de los fármacos , Glicerofosfatos/farmacología , Glucógeno Hepático/metabolismo , Hígado/metabolismo , Triosas/farmacología , Animales , Cricetinae , Cricetulus , Fructosadifosfatos/farmacología , Hígado/efectos de los fármacos , Hígado/enzimología , Fosfofructoquinasa-1/antagonistas & inhibidores
11.
Metabolism ; 35(2): 182-6, 1986 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3945187

RESUMEN

To assess the effects of oral intake of pyruvate and dihydroxyacetone on body composition and metabolism, rats were divided into two groups and pair-fed one of the following isocaloric diets for 112 days. The control diet was a liquid diet with the following caloric composition: 14% protein, 28% fat, and 58% carbohydrate. The experimental diet was the same as the control diet except for the partial substitution of carbohydrate content with pyruvate and dihydroxyacetone. Rats receiving the experimental diet gained less weight than rats receiving the control diet. This reduction in body weight appeared to be largely the result of inhibition of lipid accumulation. The experimental diet reduced body fat content by 32% without any significant effect on either protein or water content. Rats receiving the experimental diet did not have increased loss of calories in the stool, but had greater rates of heat production and energy expenditure, which was accompanied by an elevated plasma level of thyroxine. Furthermore, rats receiving the experimental diet had a smaller rate of lipid synthesis in their adipose tissue, and a reduced plasma insulin level. The data suggest that inhibition of gain in weight with the addition of pyruvate and dihydroxyacetone to the diet is the result of an increased loss of calories as heat at the expense of storage as lipid.


Asunto(s)
Dihidroxiacetona/farmacología , Metabolismo Energético , Metabolismo de los Lípidos , Piruvatos/farmacología , Triosas/farmacología , Administración Oral , Animales , Análisis Químico de la Sangre , Composición Corporal , Peso Corporal/efectos de los fármacos , Heces/análisis , Masculino , Matemática , Ácido Pirúvico , Ratas , Ratas Endogámicas
12.
Farmakol Toksikol ; 48(5): 63-5, 1985.
Artículo en Ruso | MEDLINE | ID: mdl-4076421

RESUMEN

A study was made of the effect of dioxyacetone, a natural metabolite of carbohydrate metabolism, on blood rheological properties of man in vitro and experimental animals, with the drug being injected intravenously. It was discovered both in vitro and in vivo that dioxyacetone exhibits the remarkable rheological efficacy, provided its concentration in the blood amounts to 100 mg/100 ml.


Asunto(s)
Viscosidad Sanguínea/efectos de los fármacos , Dihidroxiacetona/farmacología , Agregación Eritrocitaria/efectos de los fármacos , Triosas/farmacología , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Dihidroxiacetona/administración & dosificación , Perros , Hematócrito , Humanos , Técnicas In Vitro , Infusiones Parenterales , Factores de Tiempo
13.
Biochem Med ; 33(2): 141-8, 1985 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2988519

RESUMEN

Glycerol, glycerol-3-phosphate (G3P), and dihydroxyacetone phosphate (DHAP) were evaluated as inhibitors of gluconeogenesis on rat liver enzymes in vitro, and for their effects on glucose formation in vivo in well-nourished and malnourished rats. DHAP was more potent as an inhibitor than G3P on fructose-1,6-diphosphatase (FDPase), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase). The I50 for DHAP was 2, 8, and 9 x 10(-3) M, respectively. No effect was observed on rat liver pyruvate carboxylase (PC). Glycerol was a weak inhibitor of FDPase and PEPCK, but did not inhibit PC and G6Pase. In vivo, when G3P was injected before a parenteral L-alanine (Ala) challenge, it produced a hypoglycemic effect in malnourished rats and a lesser, but noticeable, blood glucose level reduction in well-fed animals. Glycerol caused a smaller reduction in glucose formation from Ala. No comparable effects were observed after a fructose pretreatment. These results underscore the potential hypoglycemic effects of phosphorylated glycerol metabolites and identify the steps in gluconeogenesis where this action is exerted. The study also stresses the nutritional component in the glycerol intolerance syndrome, apparent from the far more severe effects observed in malnourished rats given G3P or glycerol prior to Ala.


Asunto(s)
Dihidroxiacetona Fosfato/farmacología , Gluconeogénesis/efectos de los fármacos , Glicerol/farmacología , Glicerofosfatos/farmacología , Triosas/farmacología , Alanina/farmacología , Animales , Glucemia/metabolismo , Fructosa/farmacología , Fructosa-Bifosfatasa/antagonistas & inhibidores , Glucosa-6-Fosfatasa/antagonistas & inhibidores , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Fosfoenolpiruvato Carboxiquinasa (GTP)/antagonistas & inhibidores , Desnutrición Proteico-Calórica/metabolismo , Ratas , Ratas Endogámicas , Factores de Tiempo
14.
Metabolism ; 34(2): 106-11, 1985 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3969012

RESUMEN

This study was undertaken in a system of chick embryo liver cells incubated in Earle's Basal Salt Solution with hormones. Impairment of induction of delta-aminolevulinic acid synthase (ALAS) by allyl-isopropylacetamide (AIA) was observed in the presence of glucose. Fructose and various gluconeogenic substances including gluconeogenic amino acids had a similar effect. Leucine, which is purely ketogenic, did not influence induction of ALAS. SH-containing amino acids increased induction of ALAS by AIA. The glucose analogues 3-O-methylglucose and 2-deoxyglucose did not impair induction of ALAS by AIA. The inhibitory effect of glycerol, fructose, and glycine was not affected by 3-O-methylglucose but was reversed by 2-deoxyglucose. The results indicate that the salutary effects of proteins on acute attacks of hepatic porphyria are probably caused by their gluconeogenic properties and that glucose-6-phosphate, or metabolite of glucose-6-phosphate that is not in the glycolytic pathway, is the active agent that leads to the glucose-like effect.


Asunto(s)
5-Aminolevulinato Sintetasa/antagonistas & inhibidores , Aminoácidos/farmacología , Carbohidratos/farmacología , 3-O-Metilglucosa , 5-Aminolevulinato Sintetasa/biosíntesis , Alilisopropilacetamida/metabolismo , Aminoácidos Sulfúricos/farmacología , Animales , Embrión de Pollo , Desoxiglucosa/farmacología , Dicarbetoxidihidrocolidina/metabolismo , Inducción Enzimática/efectos de los fármacos , Fructosa/farmacología , Gluconeogénesis/efectos de los fármacos , Glucosa/farmacología , Técnicas In Vitro , Hígado/embriología , Hígado/metabolismo , Metilglucósidos/farmacología , Porfirinas/metabolismo , Triosas/farmacología
15.
Transfusion ; 24(4): 327-9, 1984.
Artículo en Inglés | MEDLINE | ID: mdl-6464157

RESUMEN

Blood was stored with various combinations of 60 mM dihydroxyacetone (DHA), 80 mM pyruvate and 10 mM phosphate in citrate-phosphate-dextrose-adenine-one (CPDA-1) preservative for 42 days. During that time, DHA was found to have a beneficial effect on 2,3 diphosphoglycerate (2,3 DPG), although a deleterious effect on adenosine triphosphate (ATP). Preservatives containing pyruvate gave similar results. However, DHA and phosphate together in CPDA-1 improved both 2,3 DPG and ATP. The adverse effect on 2,3 DPG levels that phosphate normally shows was reversed by the addition of DHA. These results indicate that the addition of phosphate alone, rather than pyruvate, or pyruvate and phosphate, to DHA in CPDA-1 would be preferable to the presently licensed CPDA-1 preservative.


Asunto(s)
Adenina/farmacología , Adenosina Trifosfato/sangre , Conservación de la Sangre , Citratos/farmacología , Dihidroxiacetona/farmacología , Ácidos Difosfoglicéricos/sangre , Glucosa/farmacología , Fosfatos/farmacología , Triosas/farmacología , 2,3-Difosfoglicerato , Envejecimiento Eritrocítico/efectos de los fármacos , Eritrocitos/metabolismo , Humanos , Piruvatos/farmacología , Ácido Pirúvico
16.
Diabetologia ; 21(5): 489-94, 1981 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-6117495

RESUMEN

Pancreatic D and A cell function is deranged in streptozotocin diabetes. To investigate this, the effect of D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose and glucose variations during arginine stimulation on the release of somatostatin and glucagon from the isolated pancreas of normal and streptozotocin diabetic dogs was studied. Concentrations of the trioses, D-glyceraldehyde (1.25 and 2.5 mmol/l) and dihydroxyacetone (11 mmol/l), which normally stimulate D cells, did not influence the release of somatostatin in the diabetic dog. However, the higher concentration of D-glyceraldehyde (5 mmol/l) and dihydroxyacetone (11 mmol/l), which normally stimulate D cells, did not influence the release of somatostatin in the diabetic dog. However, the higher concentration of D-glyceraldehyde (5 mmol/l) suppressed D cell ssecretion in the diabetic animals at 0 and 8.3 mmol/l glucose. A cell secretion was significantly suppressed at the higher glucose level in response to both 2.5 and 5 mmol/l of te triose. This inhibition may be explained by a non-specific effect induced by the high dose of this triose. The addition of 5 mmol/l mannoheptulose, which normally reduces glucose-induced somatostatin secretion and stimulates glucagon release, did not affect hormone secretion. In both the diabetic and the normal animals, arginine (5 mmol/l) stimulated somatostatin and glucagon secretion. Although arginine was able to stimulate D and A cell secretion in the diabetic dogs, it was however unable to restore the response to changes in glucose concentration between 1.4 and 8.3 mmol/l to normal. These results demonstrate that the abnormal pancreatic D and A cell function in streptozotocin diabetes is characterised by an impaired response to glucose and certain glucose metabolites and probably results from a specific defect in glucose recognition.


Asunto(s)
Arginina/farmacología , Diabetes Mellitus Experimental/fisiopatología , Dihidroxiacetona/farmacología , Glucosa/farmacología , Gliceraldehído/farmacología , Heptosas/farmacología , Islotes Pancreáticos/fisiopatología , Manoheptulosa/farmacología , Triosas/farmacología , Animales , Perros , Glucagón/metabolismo , Técnicas In Vitro , Insulina/metabolismo , Secreción de Insulina , Somatostatina/metabolismo
17.
Biochim Biophys Acta ; 675(3-4): 309-15, 1981 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-6268188

RESUMEN

1. Epinephrine, isoproterenol and phenylephrine each increases significantly gluconeogenesis (from dihydroxy-acetone or D-fructose) and glycogenolysis when added to hepatocytes from 48-h fasted rabbits. Such stimulation of both processes by epinephrine, isoproterenol or phenylephrine is negated by the beta-adrenergic antagonist propranolol but remains significant in the presence of the alpha-adrenergic antagonist phentolamine. Conversely, previous data suggest that catecholamine-induced stimulation of glucose formation from L-lactate is both alpha- and beta-adrenergic-sensitive. 2. Glucagon, epinephrine, isoproterenol, phenylephrine and dibutyryl cyclic AMP each inhibits significantly pyruvate kinase activity in rabbit hepatocytes. Inhibition of pyruvate kinase activity by epinephrine, isoproterenol or phenylephrine is negated by propranolol but insensitive to phentolamine. 3. These observations suggest that enhancement by epinephrine of glucose formation from either dihydroxyacetone or D-fructose is solely beta-adrenergic-regulated, just as is its inhibition of pyruvate kinase activity. Stimulation of gluconeogenesis by glucagon, epinephrine, isoproterenol, phenylephrine or dibutyryl cyclic AMP may be at least in part directly related to their ability to inhibit pyruvate kinase.


Asunto(s)
Dihidroxiacetona/farmacología , Fructosa/farmacología , Glucagón/farmacología , Gluconeogénesis/efectos de los fármacos , Hígado/metabolismo , Piruvato Quinasa/antagonistas & inhibidores , Simpaticolíticos/farmacología , Simpatomiméticos/farmacología , Triosas/farmacología , Animales , Bucladesina/farmacología , Epinefrina/farmacología , Hígado/citología , Glucógeno Hepático/metabolismo , Masculino , Conejos
18.
Antimicrob Agents Chemother ; 19(4): 678-81, 1981 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7018394

RESUMEN

The fluoro and chloro analogs of glycerol 3-phosphate inhibit the growth of Escherichia coli and affect bacterial enzymes involved in lipid synthesis.


Asunto(s)
Dihidroxiacetona Fosfato/farmacología , Escherichia coli/efectos de los fármacos , Glicerofosfatos/farmacología , Triosas/farmacología , Dihidroxiacetona Fosfato/análogos & derivados , Cinética , Factores de Tiempo
19.
Diabetes ; 30(3): 203-10, 1981 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-6110600

RESUMEN

To investigate how the D-cell recognizes the glucose stimulus, the hormone response to (1) glucose, (2) the trioses glyceraldehyde and dihydroxyacetone, (3) the metabolic blocker, mannoheptulose, and (4) the low- or nonmetabolized sugars galactose, fructose, or ribose were studied using the isolated dog pancreas. We found (1) a sigmoidal relationship between extracellular glucose concentrations and the somatostatin release. The threshold concentration was around 5 mM and the largest increase in somatostatin release occurs between 5 and 10 mM of glucose. (2) Glyceraldehyde at concentrations ranging between 1.25 and 5 mM stimulated the release of somatostatin, whereas the higher concentrations of 10 and 20 mM were suppressive. Dihydroxyacetone (11 mM), also initiated somatostatin release in the absence of glucose. Both of the trioses stimulated B- and inhibited A-cell secretion. (3) Mannoheptulose (5 mM) attenuated somatostatin and insulin secretion to 8.3 mM glucose, while it augmented glucagon output. In contrast, mannoheptulose (5 mM) did not affect D-, A-, or B-cell responses to glyceraldehyde (5 mM) in the absence of glucose. (4) The somatostatin, insulin, and glucagon release remained unchanged when 8.3 mM of either galactose, fructose, or ribose was added. The results suggest that the initiation of glucose-mediated D- as well as A- and B-cell responses depends on the metabolism of the sugar.


Asunto(s)
Dihidroxiacetona/farmacología , Glucosa/farmacología , Gliceraldehído/farmacología , Heptosas/farmacología , Islotes Pancreáticos/efectos de los fármacos , Manoheptulosa/farmacología , Triosas/farmacología , Animales , Perros , Relación Dosis-Respuesta a Droga , Fructosa/farmacología , Galactosa/farmacología , Glucagón/metabolismo , Técnicas In Vitro , Insulina/metabolismo , Secreción de Insulina , Islotes Pancreáticos/metabolismo , Ribosa/farmacología , Somatostatina/metabolismo
20.
Vox Sang ; 41(1): 11-7, 1981.
Artículo en Inglés | MEDLINE | ID: mdl-7324438

RESUMEN

Units of CPDA-1 whole blood were subdivided and each treated with additions of dihydroxyacetone (DHA) to give final concentrations from 0 to 80 mM. The 'optimum' concentration of DHA to maintain 2,3-diphosphoglycerate (2,3-DPG) with minimal loss of ATP during 42 days of storage appeared to be 30 mM of DHA. With this formulation, red cell 2,3-DPG concentrations rose to 130-140% of normal by 14 days and then decreased in a near-linear manner to 50-60% normal by 42 days, while maintaining adequate ATP levels. In addition, packed red cells were prepared form CPD fresh blood and treated with adenine, glucose, and various concentrations (0-80 mM) of DHA. The cells also responded most favorably to 30mM DHA, although the response was not as positive as whole blood. This concentration of DHA produced nearly 100% maintenance of 2,3-DPG at 14 days with subsequent fall to 30% of normal by 42 days.


Asunto(s)
Adenosina Trifosfato/sangre , Conservación de la Sangre , Dihidroxiacetona/farmacología , Ácidos Difosfoglicéricos/sangre , Eritrocitos/metabolismo , Triosas/farmacología , 2,3-Difosfoglicerato , Adenina/farmacología , Citratos/farmacología , Glucosa/farmacología , Hematócrito , Humanos , Concentración de Iones de Hidrógeno , Fosfatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA